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Klf4, and c-Myc.
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We used the CytoTune-iPS 2.0 Sendai Reprogramming Kit
(Invitrogen), which contains reprogramming vectors of the four
Yamanaka factors, Oct, Sox2, Klf4, and c-Myc that have been shown to
be sufﬁcient for efﬁcient reprogramming (Lieu et al., 2013; Takahashi
et al., 2007).We conﬁrmed development of human iPSC by Karyotypingn Clinical Center, Edith Nourse
00 Springs Road, Bedford, MA
ss article under the CC BY-NC-ND lic(Fig. 1) and immunohistochemistry, using antibody against TRA-1-81
(Fig. 2A).
The CytoTune-iPS 2.0 Reprogramming System uses vectors that are
non-integrating and remain in the cytoplasm. In addition, the host cell
can be cleared of the vectors and reprogramming factor genes by
exploiting the cytoplasmic nature of SeV and the temperature sensitiv-
ity of functional mutations introduced into the key viral proteins. We
searched for any remaining SeV protein by immunohistochemistry
using Anti-SeV antibody (MBL international) and conﬁrmed that there
is no trace of viral protein (Fig. 2B).
To demonstrate three germ layer differentiation capacities, we tested
differentiation in vitro by embryoid body (EB) formation and checked
it using three different antibodies, i.e., Ectoderm: Beta III tubulin antibody,
Mesoderm: Smoothmuscle actin antibody, Endoderm: Alpha fetoprotein
antibody. Our immunostaining results demonstrated differentiation
capacity (Fig. 3).
3. Materials and methods
3.1. Human blood sample
The blood sample was donated by the patient with clinically diag-
nosed frontotemporal dementia (FTD) hospitalized at the Bedford VA
Hospital Special Dementia Care Unit, which is a hospice unit staffed
and managed by the Bedford GRECC. Blood was collected in Vacutainer
cell preparation tube (CPT) (Becton, Dickinson and Company, Franklin
Lakes, NJ). Peripheral blood mononuclear cells (PBMCs) were prepared
within one hour of blood collection. Blood samples were centrifuged at
1500 rcf for 20 min at room temperature, and the PBMC were trans-
ferred to a fresh tube, washed with PBS, and centrifuged at 300 rcf for
10 min at room temperature. Cell pellets were resuspended in PBMC
medium (Invitrogen) containing growth factors for transduction.ense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Karyotyping of iPSC (I1-12C). All ten metaphase cells counted at the microscope
(Quick Scan) had 46 chromosomes and had XY sex chromosomes characteristic of a
male patient.
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Induced PSC were generated from freshly collected, peripheral
blood-derived PBMC (Chou et al., 2011). Cells were transduced with
the integration-free CytoTune-iPS Sendai Reprogramming Kit, which
utilizes Sendai virus particles of the four Yamanaka factors (Lieu et al.,
2013; Takahashi et al., 2007). Transduced cells were plated with MEFFig. 2. Characterization of Induced pluripotent stem cells (iPSCs). A human embryonic stem c
Antigens Tra-1-81 (Fig. 2A left: Tra-1-81 staining;middle: bright ﬁeld; right: highmagniﬁcation
against SeV protein (Fig. 2B, left), compared to positive cells (Fig. 2B, right, “Con”) at much earfeeder cells, and fed iPSCmediumwith freshly added bFGF (Invitrogen)
until small colonies were formed in about 2weeks. Growth of small col-
onies was maintained for another two weeks before each colony was
picked for expansion into individual iPSC lines. After successful forma-
tion of iPSC colonies, iPSCs were transferred to plates coated with
Geltrex (Invitrogen) and cultured and expanded with E8 medium
(Invitrogen).
3.3. Live staining of iPSC
Purity and pluripotency of iPSCs grown on bothMEF feeder cells and
Geltrex coated plates were conﬁrmed using live staining with Tra-1-60
and Tra-1-81 antibodies (Invitrogen). Cells werewashedwith knockout
DMEM and stained with Tra-1-60, Tra-1-81 antibodies at 1:200 dilu-
tions. After 1 h in the CO2 incubator, cells were washed twice with KO
DMEM and incubated with secondary anti-mouse antibody conjugated
with Alexa Fluor 488 for one hour. Finally cells were washed with KO
DMEM and iPSC growth medium was added for microscopic imaging.
Images were acquired using a Leica TCS SP5 Confocal Laser Scanning
Microscope.
3.4. iPSC karyotyping
Karyotyping of our iPSC was carried out at the CytoGenomics Core
Laboratory (Brigham and Women's Hospital, Harvard Medical School,
Boston, MA). G-banding was used to karyotype our iPSC line. Cells in a
stage of active division in metaphase were arrested, harvested and
ﬁxed with Methanol:Acetic acid (3:1). The cell pellet was washed, re-
suspended, dropped on a slide and dried on a hotplate. Cells were
stained with Giemsa and the metaphase chromosome number fromell is deﬁned by the expression of cell surface proteins, such as Sialylated Keratan Sulfate
) and Tra-1-60 (not shown). There is no trace of Sendai virus protein, detected by antibody
lier passage stage when SeV protein was present.
Fig. 3. Characterization of Embryoid body (EB) formation.Undifferentiated iPSCswere cul-
tured in E6mediumwithout bFGF for 7 days. Developed EBs were transferred to a Geltrex
coated tissue culture dish and cultured an additional 12 days. EBs were ﬁxed with 4% PFA
and immuostained with three different antibodies (Ectoderm: Beta III tubulin; Green,
Mesoderm: Smooth muscle actin; SMA, Red, Endoderm: Alpha fetoprotein; Green, AFP).
Con: cells were stained in the absence of primary antibodies.
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and imaged by a Cyto Vision Software.
3.5. Three germ layer in vitro differentiation and characterization
The differentiation ability of iPSC lines was analyzed by in vitro em-
bryoid body (EB) formation, based on the previously published protocol
(Carpenter et al., 2003; Itskovitz-Eldor et al., 2000). Brieﬂy, undifferen-
tiated iPSC colonies were transferred into the non-adherent poly-HEMA
(Sigma) coated petri dish and were cultured in E6 medium withoutbFGF for 7 days. The resulting EB, which theoretically comprise three
embryonic germ layers, were plated onto Geltrex coated tissue culture
dishes and cultured for spontaneous differentiation. After cells were dif-
ferentiated in EB culture for total 19 days, cells were ﬁxed with 4% PFA
and immuostained with three different antibodies (Ectoderm: Beta III
tubulin; Sigma, Mesoderm: Smooth muscle actin; Invitrogen, Endo-
derm: Alpha fetoprotein; Invitrogen). Images were acquired using the
Nikon TMS, 10X; the Leica TCS SP5 Confocal Microscope, 10X; and the
AmScope microscope digital camera.
4. Veriﬁcation and authentication
Karyotyping of our cells was performed at the CytoGenomics Core
Laboratory (Brigham and Women's Hospital, Harvard Medical School,
Boston, MA). All ten metaphase cells counted at the microscope
(Quick Scan) had 46 chromosomes and had XY sex chromosomes
characteristic of a male patient (Fig. 1).
To conﬁrm iPS identity and purity, we checked embryonic stem cell
makers, Tra-1-81 (Fig. 2A) and Tra-1-60 (not shown) by live staining
and found all cells are Tra-1-81 positive.
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